CNS Therapeutics, Inc. was a U.S. specialty pharmaceutical company focused on therapies delivered directly into the central nervous system. It developed and marketed Gablofen…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see CNS Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks CNS Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.